VGMHealthcare MSO
Full Menu Search

The PHE Will End May 11

Published in VGM Government Relations on January 31, 2023

President Biden has announced that the COVID-19 Public Health Emergency (PHE) will officially end on May 11, 2023. This PHE was initially announced in early 2020 and has been renewed in multiple 90-day increments since then, most recently on Jan. 11.  

What Ending the PHE Means for DMEPOS Suppliers 

There are several provisions which impact the DMEPOS industry tied to the duration of the PHE. With the official ending of the PHE now in sight, most of those provisions and waivers that are still in place will end on May 11, 2023. Those waivers impacted signature/documentation requirements, reimbursement methodology, and modified medical policies (LCD), etc. A full list of all waivers can be found here, and the waivers specific to DMEPOS suppliers can be found here.  

For those beneficiaries that received equipment with a waiver, we are still awaiting direction from CMS. When we met with CMS in the past to share concerns regarding patients in the post-PHE transition, CMS representatives indicated they would provide ample time with instruction. Once we receive this direction from CMS and the local DME MACs, we will provide the information to the supplier community.  

In the meantime, start running reports in your billing software looking for those claims with the CR modifier and claim narrative (COVID-19). Know the status of those beneficiaries and claims in preparation for any instruction we shall receive. 

Regarding the 75/25 blended reimbursement rates for providers serving Medicare beneficiaries in non-rural, non-competitive bid areas, these rates will not expire with the PHE, as first intended. Introduced and implemented by CMS after the passage of the CARES Act in March 2020, these increased reimbursement rates were initially tied to the PHE, meaning they would go away as soon as the PHE was officially ended. However, the Omnibus bill passed at the end of 2022 ensured that those 75/25 blended rates would remain in place through the end of 2023 if the PHE ended during 2023.  

That means that reimbursement for DMEPOS providers will be as follows: 

  • Providers serving Medicare beneficiaries located within CBAs will continue to receive the CBA rates (the higher blended rates were never applied in these areas). 
  • Providers serving Medicare beneficiaries located in non-rural, non-competitive bid areas will receive the 75/25 blended rates for dates of service up to and including Dec. 31, 2023. On Jan. 1, 2024, those blended rates will end, and reimbursement will revert to rates similar to what was in place prior to the PHE. Those pre-pandemic rates, however, will be adjusted based on the CPI-U increases for 2022 (between 5.1 and 5.4%) and 2023 (between 6.4 and 9.1%). 
  • Providers serving Medicare beneficiaries in rural areas will continue to receive the 50/50 blended rates indefinitely. These rural rates have been in place since 2018, prior to the PHE declaration, and will remain in effect until further rulemaking changes them. They will not end when the PHE does, nor will they end on Dec. 31, 2023, with the 75/25 blended rates. 

As always, the experts in VGM Government Relations will continue to monitor the changes and updates and communicate additional details as needed. Feel free to contact us with any questions related to this topic.  

TAGS

  1. phe
  2. vgm
  3. vgm government

From Our Experts

Showing Up...It Matters! thumbnail Showing Up...It Matters! We've all heard the phrase, "Showing up matters." That can mean a lot of different things at different times in our lives, even changing daily. Perhaps it means leaving work early to attend your children's event. Maybe it means not missing that important meeting at work. No doubt, both of those things are important. For us here in the Government Relations corner of VGM Group, it means something additional. Matthew Flatt: A Champion for Change in Home Medical Equipment thumbnail Matthew Flatt: A Champion for Change in Home Medical Equipment In every industry, there are people who do more than simply lead organizations. They inspire progress, build relationships, and create lasting change. In the home medical equipment (HME) industry, Matthew Flatt, CEO of Medicap Home Medical (formerly NuCara Home Medical) and President of the Midwest Association for Medical Equipment Services (MAMES), is one of those individuals... Full Legislative Text Released for Bipartisan Ostomy and Urological Supply Bill- H.R. 10787 thumbnail Full Legislative Text Released for Bipartisan Ostomy and Urological Supply Bill- H.R. 10787 Representatives Brad Schneider (IL-10) and Greg Murphy, M.D. (NC-03) have introduced the bipartisan Access to Medical Supplies Act, legislation designed to protect Medicare beneficiaries who rely on ostomy and urological supplies. The bill would... Action Alert: Support H.R. 10787 to Protect Patient Access to Urological and Ostomy Supplies thumbnail Action Alert: Support H.R. 10787 to Protect Patient Access to Urological and Ostomy Supplies The DMEPOS community has an important opportunity to protect access to vital urological and ostomy supplies for Medicare beneficiaries. Rep. Greg Murphy (R-NC) and Rep. Brad Schneider (D-IL) have introduced H.R. 10787, bipartisan legislation that would amend Title XVIII of the Social Security Act to exclude urological and ostomy supplies from Medicare competitive acquisition programs for five years... CMS Announces Registration and Bid Window Dates for Round 2028 of the DMEPOS Competitive Bidding Program thumbnail CMS Announces Registration and Bid Window Dates for Round 2028 of the DMEPOS Competitive Bidding Program Yesterday, CMS announced the Round 2028 bidding details with registration opening December 1, 2026, and the bid window opening January 5, 2027. The new Round 2028 timeline is as follows... Congratulations to CAMPS On This Important Legislative Victory thumbnail Congratulations to CAMPS On This Important Legislative Victory The signing of AB 1794 is another reminder of the critical role state associations play in shaping healthcare policy, removing barriers to patient care, and ensuring providers have a seat at the table when important decisions are made. Legislative successes like this do not happen by accident. They are the result of engaged members, strong advocacy efforts, and collaboration with policymakers to address real-world challenges facing providers and the patients they serve. S.247, Choices for Increased Mobility Act of 2025, Passes U.S. Senate thumbnail S.247, Choices for Increased Mobility Act of 2025, Passes U.S. Senate S.247, Choices for Increased Mobility Act of 2025 has passed in the Senate through unanimous consent. It now heads to the President to be signed into law. Introduced in the Senate by Sen. Tammy Duckworth (D-IL), The Choices for Increased Mobility Act of 2025 would... August Recess Recap: Building Relationships, Advancing Advocacy thumbnail August Recess Recap: Building Relationships, Advancing Advocacy As Congress worked through the August recess, the VGM Government Relations team remained actively engaged in securing meetings and building relationships with legislators, candidates, and key congressional staff across the country. This summer, the team made a strategic decision to focus getting a strong balance between Republican and Democratic offices, recognizing the importance of broadening support for DMEPOS priorities and ensuring policymakers from both parties understand the challenges..